1.86
Stereotaxis Inc stock is traded at $1.86, with a volume of 263.44K.
It is up +3.33% in the last 24 hours and down -15.45% over the past month.
Stereotaxis, Inc. designs, manufactures, and markets robotic systems and instruments for the treatment of abnormal heart rhythms in the United States and internationally. Its products include Niobe ES robotic magnetic navigation system that enables physicians to complete interventional procedures by providing image guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and Vdrive system, which offers navigation and stability for the diagnostic and therapeutic devices designed to enhance interventional procedures. The company also offers Odyssey solution, a real-time information solution to manage, control, record, and share procedures across networks. In addition, it provides disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; and CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters. Further, the company's disposables and other accessories include V-CAS and V-CAS Deflect catheter advancement systems; and V-loop circular and V-Sono ICE catheter manipulators. The company markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with Osypka AG to design and develop a next-generation magnetic ablation catheter using Stereotaxis' robotic technology. Stereotaxis, Inc. was founded in 1990 and is headquartered in St. Louis, Missouri.
See More
Previous Close:
$1.80
Open:
$1.82
24h Volume:
263.44K
Relative Volume:
0.51
Market Cap:
$180.88M
Revenue:
$32.38M
Net Income/Loss:
$-21.64M
P/E Ratio:
-7.3897
EPS:
-0.2517
Net Cash Flow:
$-13.78M
1W Performance:
+3.33%
1M Performance:
-15.45%
6M Performance:
-36.30%
1Y Performance:
-6.06%
Stereotaxis Inc Stock (STXS) Company Profile
Name
Stereotaxis Inc
Sector
Industry
Phone
314-678-6100
Address
4320 Forest Park Avenue, Suite 100, St. Louis, MO
Compare STXS vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
STXS
Stereotaxis Inc
|
1.86 | 175.05M | 32.38M | -21.64M | -13.78M | -0.2517 |
|
ISRG
Intuitive Surgical Inc
|
469.98 | 167.61B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
158.27 | 44.35B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
75.26 | 36.19B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
MDLN
Medline Inc
|
42.67 | 34.11B | 28.43B | 1.16B | 1.26B | 1.4457 |
|
RMD
Resmed Inc
|
226.31 | 33.24B | 5.40B | 1.49B | 1.78B | 10.12 |
Stereotaxis Inc Stock (STXS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-16-25 | Initiated | Citizens JMP | Mkt Outperform |
| Jan-10-24 | Initiated | ROTH MKM | Buy |
| Jul-12-22 | Initiated | Aegis Capital | Buy |
| Jun-23-22 | Initiated | B. Riley Securities | Buy |
| Jan-05-22 | Initiated | Craig Hallum | Buy |
| Jan-05-22 | Initiated | Loop Capital | Buy |
| May-26-21 | Initiated | Piper Sandler | Overweight |
| Sep-08-20 | Initiated | Northland Capital | Outperform |
| Apr-09-20 | Initiated | Cowen | Outperform |
| Apr-07-20 | Initiated | Lake Street | Buy |
View All
Stereotaxis Inc Stock (STXS) Latest News
Stereotaxis, Inc. to unveil new robotic EP solutions at EHRA2026 in Paris - Traders Union
[EFFECT] Stereotaxis, Inc. SEC Filing - Stock Titan
Aug Big Picture: Is Stereotaxis Inc being accumulated by smart moneyWeekly Earnings Recap & Real-Time Volume Surge Alerts - baoquankhu1.vn
Stereotaxis (STXS) Announces First Robotic MAGiC Sweep Catheter Procedure at Deborah Heart and Lung Center - MSN
Stereotaxis, Inc. gears up for EHRA2026 with robotic EP technology preview - Traders Union
Analyst Calls: Can Stereotaxis Inc keep up with sector leaders2026 Major Catalysts & AI Powered Trade Plan Recommendations - baoquankhu1.vn
Stereotaxis Inc. (STXS) reports Q4 loss, lags revenue estimates - MSN
Stereotaxis (NYSE American: STXS) registers $79.6M unsold securities, adds $42.1M ATM balance - Stock Titan
Stereotaxis (STXS) to Participate in BTIG Hosted Virtual Meeting - GuruFocus
Stereotaxis: Medical Robotics Upside Offsets Cash Burn And Execution Risks (NYSE:STXS) - Seeking Alpha
Stereotaxis, Inc. (AMEX:STXS) Q1 2025 Earnings Call Transcript - MSN
Stereotaxis Inc. 2025 Annual Report: Robotic Magnetic Navigation Systems, Strategic Partnerships, and Market Overview - Minichart
Stereotaxis (NYSE: STXS) details 2025 backlog, APT deal and catheter shift - Stock Titan
Stereotaxis 10-K: $32.4M Revenue, $(0.25) EPS - TradingView
32.4 million revenue surges over 20 percent with regulatory wins, Stereotaxis asserts - Traders Union
Stereotaxis (STXS) Q4 Earnings: EPS Beats, Revenue Misses - GuruFocus
Stereotaxis Inc (STXS) Q4 2025 Earnings Call Highlights: Revenue Surge and Strategic Advances ... By GuruFocus - Investing.com Canada
Stereotaxis (STXS) Achieves Regulatory Milestones and Revenue Gr - GuruFocus
Stereotaxis Q4 Earnings Call Highlights - MarketBeat
Stereotaxis Inc. (STXS) Reports Q4 Loss, Lags Revenue Estimates - Bitget
Stereotaxis earnings matched, revenue fell short of estimates By Investing.com - Investing.com Canada
Stereotaxis (STXS) Projects Strong Revenue Growth by 2026 - GuruFocus
STXS Q4 Revenue Misses Expectations; Strong Backlog Reported - GuruFocus
Stereotaxis reports 20% revenue growth - The Business Journals
Surgical robotics firm Stereotaxis Q4 revenue jumps - TradingView
Stereotaxis (NYSE: STXS) posts 20% 2025 revenue growth and eyes $40M+ in 2026 - Stock Titan
Stereotaxis Q4 Earnings Summary & Key Takeaways - Benzinga
Stereotaxis Reports 2025 Full Year Financial Results - ChartMill
Stereotaxis, Inc. schedules Q4 and full year 2025 earnings call for 4:30 PM ET - Traders Union
Surgical robotics firm Stereotaxis aims to top $40M revenue in 2026 - Stock Titan
Aug Weekly: Should I buy Stereotaxis Inc stock nowJuly 2025 Chart Watch & Fast Entry High Yield Tips - baoquankhu1.vn
AI Robot in Heart Treatment Market Is Going to Boom | Major Giants Intuitive Surgical, Stereotaxis, Auris Health - openPR.com
Stereotaxis (STXS) Set to Release Q4 Earnings with Revenue Growt - GuruFocus
Preview: Stereotaxis's Earnings - Benzinga
Stereotaxis Inc. (NYSEAMERICAN:STXS) Short Interest Update - Defense World
Treasury Yields: Should value investors consider Stereotaxis IncTrade Risk Summary & Low Risk Investment Opportunities - baoquankhu1.vn
STXS SEC FilingsStereotaxis Ord 10-K, 10-Q, 8-K Forms - Stock Titan
Robotic technology shields patients and doctors from radiation, Stereotaxis asserts - Traders Union
Short Interest in Stereotaxis Inc. (NYSEAMERICAN:STXS) Increases By 21.2% - MarketBeat
STXSStereotaxis Reports 2022 First Quarter Financial Results - mx.advfn.com
Form S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments - Revista ADVFN
Stereotaxis, Inc. promotes direct experience of RoboticEP benefits through interactive demonstration - Traders Union
Stereotaxis (STXS) Projected to Release Earnings on Monday - MarketBeat
STXS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Can Stereotaxis Inc. keep up with sector leadersJuly 2025 Final Week & Verified Chart Pattern Trade Signals - mfd.ru
Stereotaxis (NYSEAMERICAN:STXS) Shares Up 2.5%Still a Buy? - MarketBeat
Fed Watch: Does Stereotaxis Inc align with a passive investing strategyQuarterly Profit Report & Risk Controlled Stock Alerts - baoquankhu1.vn
Will Stereotaxis Inc. stock recover after earningsMarket Volume Summary & Safe Entry Trade Reports - mfd.ru
Why Stereotaxis Inc. stock is favored by top institutionsQuarterly Performance Summary & Community Consensus Stock Picks - mfd.ru
Stereotaxis to Report Fourth Quarter and Full Year 2025 Financial Results on March 9, 2026 - GlobeNewswire
Robotic surgery firm Stereotaxis to reveal 2025 results March 9 - Stock Titan
Stereotaxis Inc Stock (STXS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):